Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Condition:   COVID-19 Severe Respiratory Failure Interventions:   Drug: Dexamethasone;   Drug: Low molecular weight heparin;   Drug: Anakinra 100Mg/0.67Ml Inj Syringe;   Drug: Tocilizumab;   Drug: Baricitinib;   Drug: Dornase Alfa Inhalant Product Sponsor:   Democritus University of Thrace Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials